SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-182448
Filing Date
2017-05-25
Accepted
2017-05-25 06:15:03
Documents
3
Period of Report
2017-05-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d400295d8k.htm 8-K 17539
2 EX-1.1 d400295dex11.htm EX-1.1 184925
3 EX-5.1 d400295dex51.htm EX-5.1 8489
  Complete submission text file 0001193125-17-182448.txt   212133
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 17868231
SIC: 2836 Biological Products, (No Diagnostic Substances)